The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, přehledy, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
103838
Wellcome Trust - United Kingdom
MOP-81114
CIHR - Canada
MC_U105597119
Medical Research Council - United Kingdom
MR/M008983/1
Medical Research Council - United Kingdom
R01 NS052318
NINDS NIH HHS - United States
MC_UU_00005/12
Medical Research Council - United Kingdom
R01 NS075012
NINDS NIH HHS - United States
MR/M009041/1
Medical Research Council - United Kingdom
MR/M024873/1
Medical Research Council - United Kingdom
PubMed
28370449
DOI
10.1002/mds.26968
Knihovny.cz E-zdroje
- Klíčová slova
- 7T, MRI, Parkinson's disease, atypical parkinsonism, diffusion MRI, fMRI, iron, neuromelanin, resting state fMRI,
- MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- parkinsonské poruchy diagnostické zobrazování MeSH
- zobrazování trojrozměrné * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Research Support, N.I.H., Extramural MeSH
Historically, magnetic resonance imaging (MRI) has contributed little to the study of Parkinson's disease (PD), but modern MRI approaches have unveiled several complementary markers that are useful for research and clinical applications. Iron- and neuromelanin-sensitive MRI detect qualitative changes in the substantia nigra. Quantitative MRI markers can be derived from diffusion weighted and iron-sensitive imaging or volumetry. Functional brain alterations at rest or during task performance have been captured with functional and arterial spin labeling perfusion MRI. These markers are useful for the diagnosis of PD and atypical parkinsonism, to track disease progression from the premotor stages of these diseases and to better understand the neurobiological basis of clinical deficits. A current research goal using MRI is to generate time-dependent models of the evolution of PD biomarkers that can help understand neurodegeneration and provide reliable markers for therapeutic trials. This article reviews recent advances in MRI biomarker research at high-field (3T) and ultra high field-imaging (7T) in PD and atypical parkinsonism. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Parkinson's Disease Research Clinic Brain and Mind Centre University of Sydney Sydney Australia
Sunnybrook Health Sciences Centre University of Toronto Toronto Ontario Canada
Citace poskytuje Crossref.org